EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma

Bohan Tang, Yue Dong

The Journal of Gene Medicine · 2023

DOI: 10.1002/jgm.3490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Bohan Tang und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Epstein-Barr Virus Infections, Head and Neck Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims This study performed a network pharmacology analysis to explore the potential anticancer activity of baicalein against oral squamous cell carcinoma (OSCC).

Methods

The differentially expressed genes in OSCC were identified by the OSCC, and the key module related to OSCC was acquired by the weighted gene co‐expression network analysis from GSE30784. Baicalein targets were obtained from GeneCards, SwissTargetPrediction and TCMSP (the traditional Chinese medicine systems pharmacology database and analysis platform) databases. Apart from GSE30784, OSCC‐related genes were acquired from the Comparative Toxicogenomics Database and DisGeNET platform. The baicalein targets and OSCC‐related genes were overlapped to acquire the drug–disease interaction genes. We input the candidate drug–disease interaction genes into the STRING database and created the protein–protein interaction network. The hub genes in the network were identified by cytoHubba. The expression levels of hub genes between cancer tissues and normal tissues were evaluated based on The Cancer Genome Atlas. Moreover, we performed the cancer immune infiltration analysis and evaluated the association between the expression of HIF1A and the abundance of infiltrating immune cells. The molecular docking between HIFA and baicalein was also performed and visualized. Additionally, the enrichment analysis was performed based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes database.

Results

After overlapping the candidate baicalein targets with OSCC‐related genes, 34 candidate drug–disease interaction genes were obtained. cytoHubba identified the top 10 genes with high centrality measures from the network, including AKT1 , CD44, EGFR , HIF1A , IGF1 , MMP2 , MYC , PTGS2 , STAT3 and TP53 . The enriched biological process terms included regulation of apoptotic signaling pathway, regulation of cysteine‐type endopeptidase activity and cellular response to chemical stress. The top five enriched pathways comprised Kaposi sarcoma‐associated herpesvirus infection, hepatitis C, p53 signaling pathway, Epstein–Barr virus infection and proteoglycans in cancer. The expression of HIF1A was positively associated with the infiltration levels of CD4 + T cells (cor = 0.131, p = 0.004) and dendritic cells (cor = 0.098, p = 0.03), whereas negatively associated with B cells (cor = −0.098, p = 0.03).

Conclusion

Our results suggested that baicalein might be a candidate drug against OSCC. More studies are necessary to validate its anticancer effect and explore the underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsEpstein-Barr Virus InfectionsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckNetwork PharmacologyMolecular Docking SimulationHerpesvirus 4, HumanComputational BiologyFlavanones

Stichwörter der Autor:innen

baicaleindrug discoverynatural productsnetwork pharmacologyoral squamous cell carcinoma

Substanzen

baicaleinFlavanones

Autor:innen und Institutionen

  • School of Stomatology, Dalian Medical University, Dalian, China.
  • Osaka University Graduate School of Medicine, Osaka, Japan.

Zitieren

APA

Tang, B., & Dong, Y. (2023). Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3490

Vancouver

Tang B, Dong Y. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3490

BibTeX
@article{Tang2023,
  author = {Tang, Bohan and Dong, Yue},
  title = {Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma},
  journal = {The Journal of Gene Medicine},
  year = {2023},
  doi = {10.1002/jgm.3490}
}
Kostenlos starten →